American Regent, Inc. introduces Tralement

October 01, 2020  –  American Regent, Inc. (Melville, NY) announced the introduction of Tralement (trace elements injection 4, USP), the first and only FDA-approved multi-trace element injection.

Tralement is indicated in adult and pediatric patients weighing at least 10 kg as a source of zinc, copper, manganese, and selenium for parenteral nutrition when oral or enteral nutrition is not possible, insufficient, or contraindicated.

Going forward, American Regent has committed to addressing the needs of special patient populations through the expansion of the Tralement product line. In addition, American Regent has made significant investments in its manufacturing infrastructure to help ensure continuous supply of Tralement.

This product is available for immediate shipment, the company says.

Learn More